<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/mostaccessed/journal?journal=bmcvetres&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Veterinary Research - Most accessed articles</title>
        <link>http://www.biomedcentral.com/bmcvetres/</link>
        <description>The most accessed research articles published by BMC Veterinary Research</description>
        <dc:date>2009-11-17T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1746-6148/5/39" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1746-6148/5/40" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1746-6148/5/42" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1746-6148/5/41" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1746-6148/5/37" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1746-6148/5/33" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1746-6148/5/35" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1746-6148/5/36" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1746-6148/5/38" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1746-6148/2/12" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1746-6148/5/39">
        <title>Animal tumour registry of two provinces in northern Italy: incidence of spontaneous tumours in dogs and cats </title>
        <description>Background:
Cancer is a major cause of death in domestic animals. Furthermore, many forms of pet neoplasm resemble that of their human counterparts in biologic behaviour, pathologic expression, and recognised risk factors.In April 2005, a pilot project was activated so as to establish a dog and cat tumour registry living in the Venice and Vicenza provinces (Veneto Region, north-eastern Italy), with the aim of estimating the incidence of spontaneous tumours.
Results:
Through a telephone survey, the estimates of canine and feline populations of the catchment area turned out to be of 296,318 (CI +/- 30,201) and 214,683 (CI +/- 21,755) subjects, respectively. During the first three years, overall 2,509 canine and 494 feline cases of neoplasia were diagnosed. In dogs, the estimated annual incidence rate (IR) per 100,000 dogs for all tumours was 282 in all the catchment area, whereas in cats the IR was much lower (IR = 77). Malignant and benign tumours were equally distributed in male and female dogs, whereas cats had a 4.6-fold higher incidence of malignant tumours than benign. In both dogs and cats, purebreds had an almost 2-fold higher incidence of malignant tumours than mixed breeds. Tumour incidence increased with age in both dog and cat populations.
Conclusion:
This study has provided estimates of incidence of spontaneous neoplasm in companion animals. Further attempts will be made to increase the accuracy in the population size assessment and to ascertain the real gap with the official regional canine demographic registry. Veterinary practitioners may also benefit from the tumour registry insofar they may obtain data for specific breeds, age groups or geographical areas.</description>
        <link>http://www.biomedcentral.com/1746-6148/5/39</link>
                <dc:creator>Marta Vascellari</dc:creator>
                <dc:creator>Elisa Baioni</dc:creator>
                <dc:creator>Giuseppe Ru</dc:creator>
                <dc:creator>Antonio Carminato</dc:creator>
                <dc:creator>Franco Mutinelli</dc:creator>
                <dc:source>BMC Veterinary Research 2009, 5:39</dc:source>
        <dc:date>2009-10-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-6148-5-39</dc:identifier>
        <prism:publicationName>BMC Veterinary Research</prism:publicationName>
        <prism:issn>1746-6148</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>39</prism:startingPage>
        <prism:publicationDate>2009-10-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1746-6148/5/40">
        <title>Correction: Trace metals and over-expression of metallothioneins in bladder tumoral lesions: a case-control study</title>
        <description>No description available</description>
        <link>http://www.biomedcentral.com/1746-6148/5/40</link>
                <dc:creator>Andre Amaral</dc:creator>
                <dc:creator>Teresa Cymbron</dc:creator>
                <dc:creator>Fatima Gartner</dc:creator>
                <dc:creator>Manuela Lima</dc:creator>
                <dc:creator>Armindo Rodrigues</dc:creator>
                <dc:source>BMC Veterinary Research 2009, 5:40</dc:source>
        <dc:date>2009-11-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-6148-5-40</dc:identifier>
        <prism:publicationName>BMC Veterinary Research</prism:publicationName>
        <prism:issn>1746-6148</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>40</prism:startingPage>
        <prism:publicationDate>2009-11-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1746-6148/5/42">
        <title>Performance of TB immunodiagnostic tests in Eurasian badgers (Meles meles) of different ages and the influence of duration of infection on serological sensitivity</title>
        <description>Background:
In parts of Great Britain and Ireland, Eurasian badgers (Meles meles) constitute a reservoir of Mycobacterium bovis infection and a potential source of infection for cattle. In vitro diagnostic tests for live badgers are an important component of strategies to control TB in this species. Immunological tests have been developed for badgers, although little is known about the influence of the age of the animal on test performance. To address this, we evaluated the performance of three immunological tests for badgers with respect to the age of the animal: the Brock Test and BrockTB STAT-PAK&#174; serological tests and the recently developed interferon-gamma enzyme immunoassay (IFN&#947; EIA). Data published elsewhere suggested that seropositivity was associated with more progressive forms of TB in the badger. To gain further evidence for this, we used longitudinal data from a well-studied population of badgers to test for an association between the sensitivity of the Brock Test and the duration of TB infection.
Results:
Sensitivity of the two serological tests was approximately 54% for both cubs and adults. Sensitivity of the IFN&#947; EIA was lower in cubs (57%) compared with adults (85%) when a common cut-off value was used to define test positivity. Taking data from the cubs alone, the IFN&#947; EIA cut-off value could be adjusted to increase the sensitivity to 71% with no loss in specificity. As a general observation, specificity of all tests was higher in cubs, although only significantly so in the case of the Brock Test. Using logistic regression analysis to adjust for age, sensitivity of the Brock Test was significantly lower at first culture positive event (58%), but increased to &gt;80% as infection progressed.
Conclusion:
These data suggest that serodiagnosis could be a valuable tool for detecting a higher proportion of badgers with the greatest probability of transmitting infection. The age category of the badger appeared to exert little influence on the performance of the serological tests. Although data were only available for the IFN&#947; EIA in a small number of cubs, reduced sensitivity of the test in these individuals suggests a lower cut-off may be needed when testing younger animals.</description>
        <link>http://www.biomedcentral.com/1746-6148/5/42</link>
                <dc:creator>Mark Chambers</dc:creator>
                <dc:creator>Sue Waterhouse</dc:creator>
                <dc:creator>Konstantin Lyashchenko</dc:creator>
                <dc:creator>Richard Delahay</dc:creator>
                <dc:creator>Robin Sayers</dc:creator>
                <dc:creator>R Glyn Hewinson</dc:creator>
                <dc:source>BMC Veterinary Research 2009, 5:42</dc:source>
        <dc:date>2009-11-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-6148-5-42</dc:identifier>
        <prism:publicationName>BMC Veterinary Research</prism:publicationName>
        <prism:issn>1746-6148</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>42</prism:startingPage>
        <prism:publicationDate>2009-11-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1746-6148/5/41">
        <title>The effect of moxidectin 0,1% vs ivermectin 0,08%  on milk production in sheep naturally infected by gastrointestinal nematodes.</title>
        <description>Background:
Gastrointestinal nematode (GIN) infection is one of the main constraints to sheep production both in temperate and tropical countries. Economic losses caused by GIN are related to decreased production, treatment costs and even animal death. The present paper was aimed at assessing the anthelmintic efficacy (based on faecal egg count reduction) of moxidectin and ivermectin both admistered per os at dose rate of 0.2 mg/Kg body weight and the benefit of anthelmintic treatments on milk production in a commercial dairy sheep farms in central Italy whose animals were naturally infected by GIN.
Results:
The treatment with moxidectin was highly effective (&gt; 98%) from day 7 until day 75, and effective (90-98%) until day 105. The treatment with ivermectin was highly effective (&gt; 98%) from day 7 until day 14, effective (90-98%) at day 28 and moderately effective (80-89%) on day 45. The milk productions in the treated groups were significantly higher than those of the control group.
Conclusion:
In conclusion, the results of the present study demonstrated that moxidectin and ivermectin adminstered per os according to the manufacturer&apos;s instructions were both effective and safe anthelmintics in sheep. The total milk production was higher in the treated groups than the control group. Overall, animals treated with moxidectin had a milk production 40.8% higher than control group; whereas animals treated with ivermectin had a milk production 32.2% higher than control group.</description>
        <link>http://www.biomedcentral.com/1746-6148/5/41</link>
                <dc:creator>Giuseppe Cringoli</dc:creator>
                <dc:creator>Vincenzo Veneziano</dc:creator>
                <dc:creator>Laura Mezzino</dc:creator>
                <dc:creator>Mariaelena Morgoglione</dc:creator>
                <dc:creator>Saverio Pennacchio</dc:creator>
                <dc:creator>Laura Rinaldi</dc:creator>
                <dc:creator>Vincenzo Salamina</dc:creator>
                <dc:source>BMC Veterinary Research 2009, 5:41</dc:source>
        <dc:date>2009-11-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-6148-5-41</dc:identifier>
        <prism:publicationName>BMC Veterinary Research</prism:publicationName>
        <prism:issn>1746-6148</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>41</prism:startingPage>
        <prism:publicationDate>2009-11-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1746-6148/5/37">
        <title>Giardia duodenalis in feedlot cattle from the central and western United States. </title>
        <description>Background:
Giardia duodenalis is a ubiquitous protozoan parasite that has emerged as a significant opportunistic human pathogen. G. duodenalis may have a deleterious effect on animal growth and performance, therefore its potential as a production limiting organism should not be discounted. We therefore undertook this study to determine management and environmental factors in feedlots that influence the prevalence and environmental load of G. duodenalis cysts in fecal material deposited by feedlot cattle in the central and western United States.
Results:
Twenty two feedlots from 7 states were included in the study, and up to 240 fecal samples were collected from pen floors of up to 6 pens per feedlot. Giardia duodenalis cysts were identified and counted using direct immunofluorescent microscopy. The estimated overall point prevalence of G. duodenalis was 19.1%, representing feedlots from a wide range of climates and management systems. Pen-level prevalence varied from 0 to 63.3%, with pen-level shedding estimates ranging from 0 to 261,000 cysts/g feces. Higher environmental temperatures, increased animal density, and increased time in the feedlot were associated with a lower prevalence of G. duodenalis. Removing manure before placing a new group of cattle in a pen was associated with a decreased prevalence of G. duodenalis in fecal pats. Using coccidiostats as a feed additive was associated with a higher prevalence of Giardia.
Conclusion:
Management practices could be employed that would limit the probability that feedlot cattle shed G. duodenalis in their feces and therefore potentially limit contamination of their environment.</description>
        <link>http://www.biomedcentral.com/1746-6148/5/37</link>
                <dc:creator>Bruce Hoar</dc:creator>
                <dc:creator>Robert Paul</dc:creator>
                <dc:creator>Jennifer Siembieda</dc:creator>
                <dc:creator>Maria das Gracas Pereira</dc:creator>
                <dc:creator>Edward Atwill</dc:creator>
                <dc:source>BMC Veterinary Research 2009, 5:37</dc:source>
        <dc:date>2009-10-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-6148-5-37</dc:identifier>
        <prism:publicationName>BMC Veterinary Research</prism:publicationName>
        <prism:issn>1746-6148</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>37</prism:startingPage>
        <prism:publicationDate>2009-10-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1746-6148/5/33">
        <title>Classical sheep scrapie in Great Britain: spatial analysis and identification of environmental and farm-related risk factors </title>
        <description>Background:
Previous studies suggest that the spatial distribution of classical sheep scrapie in Great Britain is uneven and that certain flock characteristics may be associated with occurrence of the disease. However, the existence of areas of high and low disease-risk may also result from differences in the spatial distribution of environmental characteristics. In this study we explored the spatial pattern of classical scrapie in Great Britain between 2002 and 2005 and investigated the association between disease occurrence and various environmental and farm-related risk factors.
Results:
Exploratory spatial analysis: South Wales was found to have a higher density of scrapie-positive farms than the rest of Great Britain. In addition, a small cluster of high-risk farms was identified in the center of this region in which clustering of scrapie-positive farms occurred up to a distance of approximately 40 km.Spatial modelling: A mixed-effects regression model identified flock-size and soil drainage to be significantly associated with the occurrence of scrapie in England and Wales (area under the curve (AUC) 0.71 &#177; 0.01, 95% CI 0.68 - 0.74). The predictive risk map based on the estimated association between these factors and disease occurrence showed most of Wales to be at risk of being confirmed positive for scrapie with areas of highest risk in central and south Wales. In England, areas with the highest risk occurred mainly in the north and the midlands.
Conclusion:
The observed distribution of scrapie in Great Britain exhibited a definite spatial pattern with south Wales identified as an area of high occurrence. In addition both flock (flock size) and environmental variables (soil drainage) were found to be significantly associated with the occurrence of the disease. However, the model&apos;s AUC indicated unexplained variation remaining in the model and the source of this variation may lie in farm-level characteristics rather than spatially-varying ones such as environmental factors.</description>
        <link>http://www.biomedcentral.com/1746-6148/5/33</link>
                <dc:creator>Kim Stevens</dc:creator>
                <dc:creator>Victor Del Rio Vilas</dc:creator>
                <dc:creator>Javier Guitian</dc:creator>
                <dc:source>BMC Veterinary Research 2009, 5:33</dc:source>
        <dc:date>2009-09-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-6148-5-33</dc:identifier>
        <prism:publicationName>BMC Veterinary Research</prism:publicationName>
        <prism:issn>1746-6148</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>33</prism:startingPage>
        <prism:publicationDate>2009-09-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1746-6148/5/35">
        <title>Transmissibility studies of vacuolar changes in the rostral colliculus of pigs</title>
        <description>Background:
Histopathological examinations of brains from healthy pigs have revealed localised vacuolar changes, predominantly in the rostral colliculus, that are similar to the neuropil vacuolation featured in the transmissible spongiform encephalopathies and have been described in pigs challenged parenterally with the agent causing bovine spongiform encephalopathy (BSE). Feedstuff containing BSE-contaminated meat and bone meal (MBM) may have been fed to pigs prior to the ban of mammalian MBM in feed of farmed livestock in the United Kingdom in 1996, but there is no evidence of the natural occurrence of a transmissible spongiform encephalopathy (TSE) in the domestic pig. Furthermore, experimental transmission of BSE to pigs by the oral route has been unsuccessful. A study was conducted to investigate whether the localised vacuolar changes in the porcine brain were associated with a transmissible aetiology and therefore biologically significant. Two groups of ten pigs were inoculated parenterally with vacuolated rostral colliculus from healthy pigs either born before 1996 or born after 1996. Controls included ten pigs similarly inoculated with rostral colliculus from New Zealand-derived pigs and nine pigs inoculated with a bovine BSE brain homogenate.
Results:
None of the pigs inoculated with rostral colliculus developed a TSE-like neurological disease up to five years post inoculation when the study was terminated, and disease-associated prion protein, PrPd, was not detected in the brains of these pigs. By contrast, eight of nine BSE-inoculated pigs developed neurological signs, two of which had detectable PrPd by postmortem tests. No significant histopathological changes were detected to account for the clinical signs in the PrPd-negative, BSE-inoculated pigs.
Conclusion:
The findings in this study suggest that vacuolation in the porcine rostral colliculus is not caused by a transmissible agent and is probably a clinically insignificant change. The presence of neurological signs in pigs inoculated with BSE without detectable PrPd raises the possibility that the BSE agent may produce a prion disease in pigs that remains undetected by the current postmortem tests.</description>
        <link>http://www.biomedcentral.com/1746-6148/5/35</link>
                <dc:creator>Timm Konold</dc:creator>
                <dc:creator>John Spiropoulos</dc:creator>
                <dc:creator>Melanie Chaplin</dc:creator>
                <dc:creator>Leigh Thorne</dc:creator>
                <dc:creator>Yvonne Spencer</dc:creator>
                <dc:creator>Gerald Wells</dc:creator>
                <dc:creator>Steve Hawkins</dc:creator>
                <dc:source>BMC Veterinary Research 2009, 5:35</dc:source>
        <dc:date>2009-09-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-6148-5-35</dc:identifier>
        <prism:publicationName>BMC Veterinary Research</prism:publicationName>
        <prism:issn>1746-6148</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>35</prism:startingPage>
        <prism:publicationDate>2009-09-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1746-6148/5/36">
        <title>Temporal patterns of inflammatory gene expression in local tissues after banding or burdizzo castration in cattle </title>
        <description>Background:
Castration of male cattle has been shown to elicit inflammatory reactions and acute inflammation is initiated and sustained by the participation of cytokines.
Methods:
Sixty continental &#215; beef bulls (Mean age 12 &#177; (s.e.) 0.2 months; Mean weight 341 &#177; (s.e.) 3.0 kg) were blocked by weight and randomly assigned to one of three treatments (n = 20 animals per treatment): 1) untreated control (Con); 2) banding castration at 0 min (Band); 3) Burdizzo castration at 0 min (Burd). Samples of the testis, epididymis and scrotal skin were collected surgically from 5 animals from each group at 12 h, 24 h, 7 d, and 14 d post-treatment, and analysed using real-time PCR. A repeated measurement analysis (Proc GLM) was performed using SAS. If there was no treatment and time interaction, main effects of treatment by time were tested by ANOVA.
Results:
Electrophoresis data showed that by 7 d post-castration RNA isolated from all the testicle samples of the Burd castrated animals, the epididymis and middle scrotum samples from Band castrates were degraded. Transitory effects were observed in the gene expression of IFN-&#947;, IL-6, IL-8 and TNF-&#945; at 12 h and 24 h post treatment. Burd castrates had greater (P &lt; 0.05) testicular IFN-&#947; mRNA levels compared with Band and Con animals, but lower (P &lt; 0.05) testicular TNF-&#945; mRNA levels compared with Con animals. Band castrates had greater (P &lt; 0.05) testicular IL-6 mRNA levels than Burd castrates at 12 h post-castration. Burd castrates had greater (P &lt; 0.05) testicular IL-8 mRNA levels than Band and Con animals at 24 h post-castration. In the epididymis, Burd castrates had greater (P &lt; 0.05) IL-6 mRNA (both at 12 h and 24 h post treatment) and IL-8 mRNA (12 h post treatment) levels compared with Band and Con animals; Burd castrates had greater (P = 0.049) IL-10 mRNA levels than Band castrates at 12 h post-castration.
Conclusion:
Banding castration caused more inflammatory associated gene expression changes to the epididymis and scrotum than burdizzo. Burdizzo caused more severe acute inflammatory responses, in terms of pro-inflammatory cytokine gene expression, in the testis and epididymis than banding.</description>
        <link>http://www.biomedcentral.com/1746-6148/5/36</link>
                <dc:creator>Wanyong Pang</dc:creator>
                <dc:creator>Bernadette Earley</dc:creator>
                <dc:creator>Torres Sweeney</dc:creator>
                <dc:creator>Vivian Gath</dc:creator>
                <dc:creator>Mark Crowe</dc:creator>
                <dc:source>BMC Veterinary Research 2009, 5:36</dc:source>
        <dc:date>2009-09-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-6148-5-36</dc:identifier>
        <prism:publicationName>BMC Veterinary Research</prism:publicationName>
        <prism:issn>1746-6148</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>36</prism:startingPage>
        <prism:publicationDate>2009-09-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1746-6148/5/38">
        <title>The evaluation of exposure risks for natural transmission of scrapie within an infected flock</title>
        <description>Background:
Although the epidemiology of scrapie has been broadly understood for many years, attempts to introduce voluntary or compulsory controls to eradicate the disease have frequently failed. Lack of precision in defining the risk factors on farm has been one of the challenges to designing control strategies. This study attempted to define which parts of the annual flock management cycle represented the greatest risk of infection to naive lambs exposed to the farm environment at different times.
Results:
In VRQ/VRQ lambs exposed to infected sheep at pasture or during lambing, and exposed to the buildings in which lambing took place, the attack rate was high and survival times were short. Where exposure was to pasture alone the number of sheep affected in each experimental group was reduced, and survival times were longer and related to length of exposure.
Conclusion:
At the flock level, eradication and control strategies for scrapie must take into account the need to decontaminate buildings used for lambing, and to reduce (or prevent) the exposure of lambs to infected sheep, especially in the later stages of incubation, and at lambing. The potential for environmental contamination from pasture should also be considered. Genotype selection may still prove to be the only viable tool to prevent infection from contaminated pasture, reduce environmental contamination and limit direct transmission from sheep to sheep.</description>
        <link>http://www.biomedcentral.com/1746-6148/5/38</link>
                <dc:creator>Glenda Dexter</dc:creator>
                <dc:creator>Sue Tongue</dc:creator>
                <dc:creator>Lindsay Heasman</dc:creator>
                <dc:creator>Susan Bellworthy</dc:creator>
                <dc:creator>Andrew Davis</dc:creator>
                <dc:creator>S Moore</dc:creator>
                <dc:creator>Marion Simmons</dc:creator>
                <dc:creator>A Sayers</dc:creator>
                <dc:creator>Hugh Simmons</dc:creator>
                <dc:creator>Danny Matthews</dc:creator>
                <dc:source>BMC Veterinary Research 2009, 5:38</dc:source>
        <dc:date>2009-10-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-6148-5-38</dc:identifier>
        <prism:publicationName>BMC Veterinary Research</prism:publicationName>
        <prism:issn>1746-6148</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>38</prism:startingPage>
        <prism:publicationDate>2009-10-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1746-6148/2/12">
        <title>Degenerative suspensory ligament desmitis as a systemic disorder characterized by proteoglycan accumulation</title>
        <description>Background:
Degenerative suspensory ligament desmitis (DSLD) is a debilitating disorder thought to be limited to suspensory ligaments of Peruvian Pasos, Peruvian Paso crosses, Arabians, American Saddlebreds, American Quarter Horses, Thoroughbreds, and some European breeds. It frequently leads to persistent, incurable lameness and need to euthanize affected horses. The pathogenesis remains unclear, though the disease appears to run in families. Treatment and prevention are empirical and supportive, and not effective in halting the progression of the disease. Presently, the presumptive diagnosis of DSLD is obtained from patient signalment and history, clinical examination, and ultrasonographic examination of clinically affected horses, and is confirmed at post mortem examination. Presently, there are no reliable methods of diagnosing DSLD in asymptomatic horses. The goal of this study was to characterize and define the disorder in terms of tissue involvement at the macroscopic and microscopic levels.
Results:
We examined tissues and organs from 28 affected horses (22 Peruvian Pasos, 6 horses of other breeds) and from 8 control horses. Histopathological examination revealed the presence of excessive amounts of proteoglycans in the following tissues removed from DSLD-affected horses: suspensory ligaments, superficial and deep digital flexor tendons, patellar and nuchal ligaments, cardiovascular system, and sclerae. Electron microscopy demonstrated changes in diameters of collagen fibrils in the tendon, and in smooth muscle cells of the media of the aorta compatible with increased cell permeability in DSLD-affected cells. Separation of tendon extracts by gel chromatography revealed the presence of additional proteoglycan(s) in extracts from affected, but not control extracts.
Conclusion:
This study demonstrates for the first time that DSLD, a disease process previously thought to be limited to the suspensory ligaments of the distal limbs of affected horses, is in fact a systemic disorder involving tissues and organs with significant connective tissue component. Abnormal accumulation of proteoglycans between collagen and elastic fibers rather than specific collagen fibril abnormalities is the most prominent histological feature of DSLD. Because of this observation and because of the involvement of many other tendons and ligaments beside the suspensory ligament, and of non-ligamentous tissue we, therefore, propose that equine systemic proteoglycan accumulation or ESPA rather than DSLD is a more appropriate name for this condition.</description>
        <link>http://www.biomedcentral.com/1746-6148/2/12</link>
                <dc:creator>Jaroslava Halper</dc:creator>
                <dc:creator>Byoungjae Kim</dc:creator>
                <dc:creator>Ahrar Khan</dc:creator>
                <dc:creator>Jung Yoon</dc:creator>
                <dc:creator>Eric Mueller</dc:creator>
                <dc:source>BMC Veterinary Research 2006, 2:12</dc:source>
        <dc:date>2006-04-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-6148-2-12</dc:identifier>
        <prism:publicationName>BMC Veterinary Research</prism:publicationName>
        <prism:issn>1746-6148</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2006-04-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
